These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9123470)
21. Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation. Ciancio G; Burke G; Viciana A; Ruiz P; Roth D; Khan TF; Montane B; Strauss J; Miller J Transplant Proc; 1998 Jun; 30(4):1536-7. PubMed ID: 9636624 [No Abstract] [Full Text] [Related]
22. Long-term results of pancreas transplantation under tacrolius immunosuppression. Jordan ML; Shapiro R; Gritsch HA; Egidi F; Khanna A; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ Transplantation; 1999 Jan; 67(2):266-72. PubMed ID: 10075592 [TBL] [Abstract][Full Text] [Related]
23. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience. Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911 [No Abstract] [Full Text] [Related]
24. Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial. Land W; Malaise J; Sandberg J; Langrehr J; Transplant Proc; 2002 Aug; 34(5):1911-2. PubMed ID: 12176625 [No Abstract] [Full Text] [Related]
25. Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil. Kahl A; Bechstein WO; Lorenz F; Steinberg J; Pohle C; Kampf D; Müller A; Settmacher U; Neuhaus P; Frei U Transplant Proc; 2001; 33(1-2):1694-5. PubMed ID: 11267473 [No Abstract] [Full Text] [Related]
26. Tacrolimus in kidney transplantation. A clinical review. Kliem V; Brunkhorst R Nephron; 1998; 79(1):8-20. PubMed ID: 9609456 [No Abstract] [Full Text] [Related]
27. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy. Kehinde EO; Feehally J; Scriven SD; Veitch PS; Bell PR Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735 [No Abstract] [Full Text] [Related]
28. Effect of HLA matching on graft survival in live donor kidney transplantations. Velidedeoğlu E; Bilgin N; Haberal M Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491 [No Abstract] [Full Text] [Related]
29. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch. Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808 [No Abstract] [Full Text] [Related]
35. Monitoring of donor sensitization in kidney transplant recipients by flow cytometric crossmatch. Cinti P; Bachetoni A; Baiano V; Pretagostini R; Poli L; Berloco P; Renna Molajoni E; Cortesini R Transplant Proc; 1993 Dec; 25(6):3265-6. PubMed ID: 8266536 [No Abstract] [Full Text] [Related]
36. Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation. Teraoka S; Babazono T; Koike T; Abe M; Kimikawa M; Shinkai M; Haruguchi H; Hirotani S; Kitajima K; Akamatsu M Transplant Proc; 1995 Feb; 27(1):1335-9. PubMed ID: 7533381 [No Abstract] [Full Text] [Related]